Pharmaceutical Pricing and Healthcare Access

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2004

Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing

FDA In Limbo as User Fee Renewal Stuck on Capitol Hill

FDA Joins Effort to Curb Drug Patent Abuses